Volume 28, Issue 145, March 2024

Role of Artificial Intelligence in polypharmacy and medication nonadherence in Saudi Arabia

Husna Irfan Thalib¹, Sariya Khan¹, Dalaa Sheikh Saleh¹, Asim M Alshanberi^1,2, Yosra Z Alhindi³, Safaa M Alsanosi³

¹General Medicine Program, Batterjee Medical College, Jeddah, Saudi Arabia
²Department of Community Medicine, Faculty of Medicine, Umm Al- Qura University, Makkah, Saudi Arabia
³Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia

ABSTRACT

Polypharmacy and medication nonadherence are growing global challenges in healthcare, especially among the older population. The rate of both is relatively high worldwide and in Saudi Arabia, with about 50% of chronic disease patients failing to comply with their treatment regimen. These issues should be countered to improve healthcare delivery systems and quality of life. AI integration into the patient care plan may assist prevent Polypharmacy's negative consequences and encourage patients to follow their prescribed course of action. In order to provide better patient care, numerous AI initiatives have been established both domestically and outside in Saudi Arabia. For maximum use, however, the introduction of AI presents ethical and technical issues that need to be resolved. Saudi Arabia has made strides toward integrating AI into healthcare through improved rates of AI literacy and easy accessibility. To get the most out of AI, more work is necessary to get over its constraints.

Keywords: AI, Polypharmacy, medication, non-adherence, Saudi Arabia

Medical Science, 2024, 28, e24ms3321

PDF

DOI: https://doi.org/10.54905/disssi.v28i145.e24ms3321

Published: 29 March 2024